2BB score and signals
Mineralys Therapeutics, Inc.’s current 2BB score is 14 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 80 | Very Strong |
Mineralys Therapeutics, Inc. (MLYS) Stock Score & Signals
Mineralys Therapeutics, Inc. (MLYS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 14 out of 100.
Company facts
| Founded | 2019 |
| Employees | 76 |
| 52-week range | $12.59 – $47.65 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-10 | — | -0.6015 | — | $0.00 |
| 2026-11-09 | — | -0.5421 | — | $0.00 |
| 2026-08-11 | — | -0.5457 | — | $0.00 |
| 2026-05-11 | — | -0.4838 | — | $0.00 |